9-[4-[2-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenoxy]phenyl]-6-phenyl-1,3,5-triazin-2-yl]carbazole
C48H31N7O — CID 155050077
Data last refreshed: (MolForge compound catalog, from PubChem)
About 9-[4-[2-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenoxy]phenyl]-6-phenyl-1,3,5-triazin-2-yl]carbazole
9-[4-[2-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenoxy]phenyl]-6-phenyl-1,3,5-triazin-2-yl]carbazole (PubChem CID 155050077) has the molecular formula C48H31N7O and a molecular weight of 721.82 g/mol. Its IUPAC name is 9-[4-[2-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenoxy]phenyl]-6-phenyl-1,3,5-triazin-2-yl]carbazole.
Molecular Properties
| Compound Name | 9-[4-[2-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenoxy]phenyl]-6-phenyl-1,3,5-triazin-2-yl]carbazole |
|---|---|
| PubChem CID | 155050077 |
| Molecular Formula | C48H31N7O |
| Molecular Weight | 721.82 g/mol |
| Exact Mass | 721.26 |
| IUPAC Name | 9-[4-[2-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenoxy]phenyl]-6-phenyl-1,3,5-triazin-2-yl]carbazole |
| SMILES | c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc(Oc4ccccc4-c4nc(-c5ccccc5)nc(-n5c6ccccc6c6ccccc65)n4)cc3)n2)cc1 |
| InChI | InChI=1S/C48H31N7O/c1-4-16-32(17-5-1)43-49-44(33-18-6-2-7-19-33)51-45(50-43)35-28-30-36(31-29-35)56-42-27-15-12-24-39(42)47-52-46(34-20-8-3-9-21-34)53-48(54-47)55-40-25-13-10-22-37(40)38-23-11-14-26-41(38)55/h1-31H |
| InChIKey | ZWJLTDBMSZAVNU-UHFFFAOYSA-N |
| XLogP | 11.28 |
| TPSA | 91.50 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 56 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 721.82 |
| LogP ≤ 5 | 11.28 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155050077 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.